Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 1
Results: 18
Foreword.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 1, doi. 10.1007/s40261-022-01148-4
- By:
- Publication type:
- Article
Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 25, doi. 10.1007/s40261-022-01147-5
- By:
- Publication type:
- Article
Correction to: Foreword.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 3, doi. 10.1007/s40261-022-01167-1
- By:
- Publication type:
- Article
Management of Pharmacologic Adverse Effects in Advanced Liver Disease.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 33, doi. 10.1007/s40261-022-01150-w
- By:
- Publication type:
- Article
Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications).
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 15, doi. 10.1007/s40261-022-01149-3
- By:
- Publication type:
- Article
Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 5, doi. 10.1007/s40261-022-01146-6
- By:
- Publication type:
- Article
Management of Alcohol-Related Liver Disease and Its Complications.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 47, doi. 10.1007/s40261-022-01143-9
- By:
- Publication type:
- Article
General Overview About the Current Management of Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 39, doi. 10.1007/s40261-022-01142-w
- By:
- Publication type:
- Article
Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 1, doi. 10.1007/s40261-021-01098-3
- By:
- Publication type:
- Article
Nutrition and Chronic Liver Disease.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 55, doi. 10.1007/s40261-022-01141-x
- By:
- Publication type:
- Article
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [<sup>14</sup>C]-BI 425809 in Healthy Males.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 87, doi. 10.1007/s40261-021-01111-9
- By:
- Publication type:
- Article
Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 17, doi. 10.1007/s40261-021-01110-w
- By:
- Publication type:
- Article
Application of Multicriteria Decision Analysis to Determine the Value of Prophylaxis Relative to On-Demand Treatment in Hemophilia A and Emicizumab versus Replacement Therapy in the Greek Healthcare Setting.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 75, doi. 10.1007/s40261-021-01108-4
- By:
- Publication type:
- Article
Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 65, doi. 10.1007/s40261-021-01104-8
- By:
- Publication type:
- Article
Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 53, doi. 10.1007/s40261-021-01103-9
- By:
- Publication type:
- Article
Correction to: Filgotinib in Rheumatoid Arthritis: A Profile of Its Use.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Safety and Efficacy of the FLECTOR (Diclofenac Epolamine) Topical System in Children with Minor Soft Tissue Injuries: A Phase IV Non-randomized Clinical Trial.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 43, doi. 10.1007/s40261-021-01101-x
- By:
- Publication type:
- Article
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 1, p. 29, doi. 10.1007/s40261-021-01100-y
- By:
- Publication type:
- Article